MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
159.61%
Quick Ratio
159.61%
Debt to Asset Ratio
50.13%
Unit: Thousand (K) dollars
Assets Breakdown
    • Unbilled receivable from governm...
    • Prepaid clinical services, long-...
    • Short-term investments
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
50,929
50,746
53,814
16,880
Short-term investments
13,047
10,276
9,993
11,913
Accounts receivable
11
7,139
14,564
42,716
Unbilled receivable from government contracts
46,981
50,435
36,781
43,229
Prepaid expenses and other current assets
5,723
13,108
20,971
2,632
Total current assets
116,691
131,704
136,123
117,370
Property and equipment, net
5,505
4,827
5,433
6,064
Prepaid clinical services, long-term
25,218
25,218
25,218
60,116
Right-of-use assets, net
10,230
10,642
11,432
17,097
Intangible assets, net
2,461
2,643
2,826
3,009
Goodwill
4,508
4,508
4,508
4,508
Other long-term assets
572
513
539
824
Total assets
165,185
180,055
186,079
208,988
Accounts payable
16,972
24,185
21,496
53,075
Deferred revenue-Government Contract
62
23
68
64,828
Deferred revenue-Collaboration Revenue
7,719
11,716
12,952
-
Other accrued current liabilities
43,128
36,526
47,879
44,882
Current portion of operating lease liability
2,539
2,530
2,978
3,783
Current portion of liability related to sale of future royalties
2,688
1,862
1,381
2,732
Total current liabilities
73,108
76,842
86,754
169,300
Operating lease liability, net of current portion
5,268
5,438
6,007
11,661
Deferred collaboration revenue, net of current portion
1,523
445
2,024
-
Liability related to sale of future royalties, net of current portion
2,043
2,372
2,679
782
Other long-term liabilities
872
841
817
489
Total liabilities
82,814
85,938
98,281
182,232
Common stock 0.0001 par value 350,000,000 shares authorized as of june 30, 2026 and december 31, 2025 242,973,040 shares issued and 242,835,358 shares outstanding as of june 30, 2026 and 240,742,681 shares issued and 240,494,594 shares outstanding as of december 31, 2025
24
24
24
23
Additional paid-in capital
550,958
549,613
548,131
542,346
Treasury stock at cost, 137,682 shares as of june 30, 2026 and 248,087 shares as of december 31, 2025
90
497
159
371
Accumulated deficit
-468,510
-455,016
-460,195
-515,240
Accumulated other comprehensive loss
-11
-7
-3
-2
Total stockholders equity
82,371
94,117
87,798
26,756
Total liabilities and stockholders equity
165,185
180,055
186,079
208,988
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$50,929K (153.24%↑ Y/Y)Unbilled receivable fromgovernment contracts$46,981K (27.73%↑ Y/Y)Short-term investments$13,047K (111.80%↑ Y/Y)Prepaid expenses andother current assets$5,723K (87.89%↑ Y/Y)Accounts receivable$11K (-99.74%↓ Y/Y)Total current assets$116,691K (65.80%↑ Y/Y)Prepaid clinicalservices, long-term$25,218K (-58.05%↓ Y/Y)Right-of-use assets, net$10,230K (-43.60%↓ Y/Y)Property and equipment,net$5,505K (-20.52%↓ Y/Y)Goodwill$4,508K (0.00%↑ Y/Y)Intangible assets, net$2,461K (-22.90%↓ Y/Y)Other long-termassets$572K (-30.83%↓ Y/Y)Total assets$165,185K (0.67%↑ Y/Y)Total liabilities andstockholders equity$165,185K (0.67%↑ Y/Y)Total liabilities$82,814K (-36.88%↓ Y/Y)Total stockholdersequity$82,371K (150.54%↑ Y/Y)Accumulated deficit-$468,510K (7.61%↑ Y/Y)Treasury stock at cost,137,682 shares as of june...$90K (-75.48%↓ Y/Y)Accumulated othercomprehensive loss-$11K (-57.14%↓ Y/Y)Total currentliabilities$73,108K (-37.98%↓ Y/Y)Operating leaseliability, net of current...$5,268K (-58.28%↓ Y/Y)Liability related to saleof future...$2,043K (788.26%↑ Y/Y)Deferred collaborationrevenue, net of current...$1,523K Other long-termliabilities$872K (84.75%↑ Y/Y)Additional paid-in capital$550,958K (1.97%↑ Y/Y)Common stock 0.0001 parvalue 350,000,000...$24K (4.35%↑ Y/Y)Other accrued currentliabilities$43,128K (20.72%↑ Y/Y)Accounts payable$16,972K (59.95%↑ Y/Y)Deferredrevenue-Collaboration Revenue$7,719K Current portion ofliability related to sale...$2,688K (0.41%↑ Y/Y)Current portion ofoperating lease liability$2,539K (-27.17%↓ Y/Y)Deferredrevenue-Government Contract$62K (-99.91%↓ Y/Y)

Vaxart, Inc. (VXRT)

Vaxart, Inc. (VXRT)